Study identifier:D9673R00037
ClinicalTrials.gov identifier:NCT06131424
EudraCT identifier:N/A
CTIS identifier:N/A
Multicentre NIS retrospective study to know the prevalence of HER2- low,clinical characteristics,treatment patterns,associated outcome in patient with HER2-negative in metastatic breast cancer who progressed on systemic anticancer therapy
HER2-negative
N/A
No
-
All
2700
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|